Patent Settlements: FTC Gets Teva To Eschew 'No-Authorized Generic' Deals

 
• By Brenda Sandburg

Global settlement resolves charges against Teva in three pending FTC antitrust suits and expands terms of 2015 consent decree.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.

More from Generics

More from Biosimilars & Generics